Ultragenyx Pharmaceutical Inc
Closed
SectorHealthcare
33.46 3.88
Overview
Share price change
24h
Min
32.27
Max
33.49
Income | -56M -185M |
|---|---|
Sales | -71M 136M |
EPS | -1.54 |
Profit margin | -136.029 |
Employees | 1,371 |
EBITDA | -50M -155M |
Recommendations | Strong Buy |
|---|---|
12 Months Forecast | +66.12% upside |
Next Earnings | 4 sie 2026 |
|---|
Market Cap | 582M 3B |
|---|---|
Previous open | 29.58 |
Previous close | 33.46 |
News Sentiment
By Acuity
64%
36%
297 / 342 Ranking in Healthcare
Ultragenyx Pharmaceutical Inc Chart
Wyniki osiągnięte w przeszłości nie są gwarantem przyszłych wyników.
Related News
Peer Comparison
Price change
Ultragenyx Pharmaceutical Inc Forecast
Price Target
By TipRanks
12 Months Forecast
Average 53.79 USD 66.12%
High 96 USD
Low 26 USD
Based on 15 Wall Street analysts offering 12 month price targets forUltragenyx Pharmaceutical Inc - Dist in the last 3 months.
Sentiment
By Acuity
News Sentiment
Bearish Evidence
Volatility
Below average
News Volume (RCV)
Below average
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$